GGrantIndex
Sort

35,931 grants matching parkinsons

Biomarkers for Preclinical Parkinson's disease

$591,350
Jing Zhang · University Of Washington · R01 · FY2011 · NS

High-speed opto-fluidics to screen entire nervous system in aging and disease

$591,327
Adela Ben-Yakar · University Of Texas At Austin · R01 · FY2012 · AG

Basal Ganglia Cortical Coupling and Connectivity Changes in PD and DBS

$591,311
Jerrold L Vitek · University Of Minnesota · R01 · FY2021 · NS

Identifying Circuit Dynamics Underlying Motor Dysfunction in Parkinson’s Disease Using Real-Time Neural Control

$591,277
David Escobar Sanabria · Cleveland Clinic Lerner Com-Cwru · R01 · FY2024 · NS

Imaging Biomarkers of Neurotoxicity in Welders

$591,238
Brad A Racette · Washington University · R01 · FY2015 · ES

Human iPSC-based personalized cell therapy of PD

$591,114
Kwang-Soo Kim · Mclean Hospital · R01 · FY2020 · NS

Administrative Core A

$591,100
Gerard David Schellenberg · University Of Pennsylvania · U54 · FY2024 · AG

Elucidating the role of the oculomotor circuit in free viewing visual search

$591,053
James Bisley · University Of California Los Angeles · R01 · FY2022 · EY

Structure and Function of the Human PON1 Polymorphism

$591,021
Clement E Furlong · University Of Washington · R01 · FY2010 · ES

Towards Therapeutics for Neurodegenerative Diseases

$590,937
Stanley B Prusiner · University Of California, San Francisco · R37 · FY2010 · AG

Optimizing coordinated reset deep brain stimulation for Parkinson's disease

$590,908
Jing Wang · University Of Minnesota · R01 · FY2024 · NS

Basal Ganglia Cortical Coupling and Connectivity Changes in PD and DBS

$590,873
Jerrold L Vitek · University Of Minnesota · R01 · FY2016 · NS

Cortical Alpha-Synuclein in Dementia

$590,765
Georgina Aldridge · University Of Iowa · R01 · FY2023 · NS

Parkinsonism-Related Changes in Activity of Cortical Projection Neurons in Monkeys

$590,752
Adriana Galvan · Emory University · P50 · FY2025 · NS

Precision-Mapping Functional Connectivity in Parkinson's Disease

$590,534
Meghan C Campbell · Washington University · R01 · FY2024 · NS

COENZYME Q10 IN EARLY PARKINSONS DISEASE

$590,497
University Of California San Diego · R01 · FY2000 · NS

The effects of parkinsonism and deep brain stimulation on basal ganglia-thalamocortical circuitry during sleep-wake behavior

$590,469
Luke Aaron Johnson · University Of Minnesota · R01 · FY2020 · NS

Mesenchymal Stem Cell Derived A-1 Exosomes for Traumatic Brain Injury

$590,351
Darwin Johnson Prockop · Texas A&M University Health Science Ctr · R01 · FY2018 · NS

NOVEL PET MARKERS OF COGNITIVE IMPAIRMENT IN MANGANESE NEUROTOXICITY

$590,318
Susan Criswell · Washington University · R01 · FY2022 · ES

Technologies enabling robust closed-loop manufacturing of human pluripotent stem cell-derived cardiomyocytes

$590,283
Sean P Palecek · University Of Wisconsin-Madison · R01 · FY2025 · HL

An Interneuron-based Cell Therapy for Epilepsy

$590,267
Scott Charles Baraban · University Of California, San Francisco · R37 · FY2016 · NS

Targeting the FBXW7/PGC1 Pathway as a Therapeutic Strategy for Parkinson's Disease

$590,222
David K. Simon · Beth Israel Deaconess Medical Center · R01 · FY2025 · NS

High-throughput neurovascular-unit-on-a-chip with OASIS for modeling Parkinson's disease

$590,144
Deok-Ho Kim · Johns Hopkins University · R01 · FY2024 · NS

Genetic Silencing of Striatal CaV1.3 Calcium Channels as a Potent Antidyskinetic Therapy for PD

$590,058
Kathy Steece Steece-Collier · Michigan State University · R01 · FY2020 · NS

Rational derivation of DA neuron subtypes from iPS cells for improved modelling of Parkinson's disease

$590,055
Dimitri Krainc · Northwestern University At Chicago · R01 · FY2018 · NS